CANADIAN WEEKLY STOCK REPORT
Aptose Biosciences Inc. (TSX:APS), Canada's 31st largest Biotechnology company by market cap, has increased 5.0c (or 3.5%) in the past week to close at CAD1.49, ending a two-week streak of losses. Compared with the S&P/TSX 60 Index which rose 6.8 points (or 0.8%) in the week, this represented a relative price increase of 2.7%. The volume was 0.02 times average trading per week of 2.1 million shares. In the past week the market cap has risen CAD0.8 million.
RelSci News & Alerts gets you: